Anesthesia devices Market Regional Analysis:
North America Market Insights
North America region is anticipated to hold lucrative anesthesia devices market share of 39.8% by the end of 2035. The market growth is expected on the account of a higher number of people suffering from chronic disease and a higher number of people who need organ transplantation. Organ transplants are often required in lifesaving situations and surgeries when a disease or illness progresses to later stages. The burden of chronic diseases is increasing in the U.S. as a result of a sedentary lifestyle, rising disposable income, and a higher life expectancy. Such diseases have become a leading cause of mortality. As per the statistics of the Centers for Disease Control and Prevention, 6 out of 10 U.S. adults are living with a chronic illness and every 4 out of 10 people have at least 1 chronic condition. Moreover, there are currently close to 121,000 people in need of kidney transplants in the United States.
Furthermore, in the US, the prevalence of diseases, including cancer and cardiovascular conditions is rising quickly. Nearly half of Americans, including those with hypertension, coronary heart disease, etc., had some form of cardiovascular disease, according to data from the American Heart Association that was released in January 2019. These illnesses usually necessitate procedures such as angioplasty, bypass, and so on, which helps to fuel the market for anesthetic devices rising demand. Additionally, according to GLOBOCON 2020, there were 612,390 fatalities and 2,281,658 new cancer cases reported in the United States in 2020. The increasing incidence of cancer cases suggests the need for more cancer-related surgeries and cancer services which are estimated to raise the need for anesthetic equipment in the area. Hence, it is predicted to surge the market growth.
